Ziprasidone: Long-term post-switch efficacy in schizophrenia

被引：2
|
作者：
Dunn, J
Simpson, GM
Fayek, M
Weiden, PJ
Murray, S
Warrington, L
Loebel, A
机构：
[1] Pfizer Inc, CNS Med, New York, NY USA
[2] Univ So Calif, Los Angeles Cty Med Ctr, Los Angeles, CA 90033 USA
[3] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2004年 / 14卷
关键词：
D O I：
10.1016/S0924-977X(04)80305-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S269 / S270
页数：2
相关论文
共 50 条
  • [31] Long-term cognitive improvement in patients switched to ziprasidone
    Loebel, A
    Harvey, PD
    Murray, S
    [J]. BIOLOGICAL PSYCHIATRY, 2004, 55 : 133S - 133S
  • [32] Long-Term Safety and Tolerability of Ziprasidone in Children and Adolescents
    Findling, Robert L.
    DelBello, Melissa P.
    Wang, Paul. P.
    Bachinsky, Mary
    Gundapaneni, Balarama
    Versavel, Mark
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 639 - 639
  • [33] Missing data and dropouts in a long-term, double-blind schizophrenia study comparing ziprasidone and haloperidol
    Siu, C.
    Potkin, S.
    Pappadopulos, E.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 161 - 161
  • [34] Long-term cognitive improvement in patients switched to ziprasidone
    Harvey, PD
    Loebel, A
    Murray, S
    Batzar, E
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S416 - S416
  • [35] Long-term cognitive improvement: Ziprasidone versus olanzapine
    Harvey, PD
    Bowie, C
    Loebel, A
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S415 - S415
  • [36] Efficacy of ziprasidone against hostility in schizophrenia
    Citrome, L.
    Volavka, J.
    Czobor, P.
    Brook, S.
    Loebel, A.
    Mandel, F.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S278 - S278
  • [37] Predictors of long-term outcome in schizophrenia: A double-blind, 196-week study of ziprasidone and haloperidol
    Loebel, Antony
    Potkin, Steven G.
    Harvey, Philip
    Warrington, Lewis
    Siu, Cynthia
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S252 - S252
  • [38] Predictors of long-term outcome in schizophrenia: A double-blind, 196-week study of ziprasidone and haloperidol
    Loebel, A.
    Potkin, S.
    Harvey, P.
    Warrington, L.
    Siu, C.
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 442 - 442
  • [39] A LONG-TERM EFFICACY AND TOXICITY STUDY OF FLUSPIRILENE IN CHRONIC-SCHIZOPHRENIA
    LAPIERRE, YD
    CHAUDHRY, R
    SIPOS, V
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1981, 30 (05): : 793 - 802
  • [40] Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia
    Daniel, DG
    Wozniak, P
    Mack, RJ
    McCarthy, BG
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 1998, 34 (01) : 61 - 69
12345